- Life Sciences Industry
R&D Tax Credits for Life Sciences Companies
Life sciences companies are at the forefront of innovation, developing treatments and technologies that save lives. Your research and development efforts qualify for substantial federal and state tax credits.
Average Credit Value
$2M - $10M+
Why Life Sciences Companies Benefit
The life sciences industry's intensive R&D requirements create exceptional tax credit opportunities
Extensive R&D Activities
From early-stage research through clinical trials, nearly every phase of development qualifies for credits.
Regulatory Documentation
FDA requirements create comprehensive documentation that strongly supports R&D tax credit claims.
Long Development Cycles
Multi-year development processes accumulate significant qualifying expenses and valuable tax credits.
Qualifying R&D Activities
Common life sciences activities that qualify for R&D tax credits
Drug Discovery & Development
- Developing new drug compounds and formulations
- Conducting preclinical research and testing
- Performing clinical trials and studies
- Creating drug delivery systems
- Developing combination therapies
Medical Device Innovation
- Designing new medical devices and instruments
- Developing diagnostic equipment
- Creating implantable devices
- Improving device biocompatibility
- Developing digital health technologies
Biotechnology Research
- Developing gene therapies and cell therapies
- Creating monoclonal antibodies
- Advancing protein engineering
- Developing biosimilars
- Creating personalized medicine approaches
Laboratory & Testing Methods
- Developing new assay methods
- Creating analytical techniques
- Improving quality control processes
- Developing biomarkers
- Creating diagnostic tests
This is not an exhaustive list. Many other life sciences R&D activities may qualify.
Success Stories
Real examples of life sciences companies benefiting from R&D tax credits
$3.2 Million
Biotech Startup
Company claimed credits for developing novel gene therapy approaches and conducting preclinical studies.
$1.8 Million
Medical Device Manufacturer
Firm received credits for creating innovative surgical instruments and conducting biocompatibility testing.
$4.5 Million
Pharmaceutical Developer
Company claimed credits for drug discovery, formulation development, and clinical trial activities.
Ready to Accelerate Your Life Sciences Innovation?
Our specialized team understands the unique challenges in life sciences R&D. Let us help you maximize your tax savings while you focus on developing breakthrough therapies and technologies.